Bullous Pemphigoid (BP) Completed Phase 3 Trials for Rituximab (DB00073)

Also known as: Pemphigoid, Bullous / Bullous Pemphigoid / Pemphigoid / Bullous pemphigoid NOS

IndicationStatusPhase
DBCOND0074370 (Bullous Pemphigoid (BP))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00525616Efficiency and Tolerance of Rituximab (mabthéra) in Bullous PemphigoidTreatment